<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02321410</url>
  </required_header>
  <id_info>
    <org_study_id>CE 2674</org_study_id>
    <nct_id>NCT02321410</nct_id>
  </id_info>
  <brief_title>&quot;In Vivo&quot; Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization</brief_title>
  <acronym>PLAVASC</acronym>
  <official_title>Plaque Neovascularization Assessment by Contrast Ultrasounds and Plaque Magnetic Resonance: &quot;in Vivo&quot; Comparison in Human Carotid Atherosclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale San Giovanni Bellinzona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale San Giovanni Bellinzona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atherosclerosis may initiate early in life and takes years to progress. This contrasts to the&#xD;
      abrupt coronary or cerebrovascular events occurring following the transition from a stable to&#xD;
      an unstable atherosclerotic plaque. The causes of this discontinuity of the disease are&#xD;
      complex and probably multiple. There is increasing evidence that, besides inflammation,&#xD;
      neovascularisation of atherosclerotic plaques and intra-plaque hemorrhages play an important&#xD;
      role in plaque instability ending-up frequently in acute thrombotic occlusion or distal&#xD;
      embolisation of athero-thrombotic material associated with heart attack or stroke.&#xD;
      Contrast-enhanced Ultrasound, is a bed-side non-invasive technique, which allows to enhance&#xD;
      microvascular structures and to visualize the adventitia and intraplaque vascularization.&#xD;
      Dynamic contrast-enhanced plaque MRI (DCE-MRI) which has also been evaluated for in vivo&#xD;
      detection and quantification of plaque neovascularity. Together with the presence of a large&#xD;
      lipid-rich core, thin fibrous cap, positive remodeling and active inflammatory infiltrate,&#xD;
      plaque neovascularisation is considered a valid marker of high-risk (or vulnerable) plaque as&#xD;
      demonstrated in histopathological studies using microvessel density.&#xD;
&#xD;
      Aim of the study is to assess and validate the value of contrast enhanced ultrasound (CEUS),&#xD;
      a bed-side technique, in detecting plaque neovascularisation and compare it with the&#xD;
      quantitative assessment by DCE-MRI in carotis atherosclerosis.&#xD;
&#xD;
      A group of 30 patients with asymptomatic carotid atherosclerosis (&gt; 50% stenosis on Doppler&#xD;
      ultrasound) will undergo Carotid Duplex ultrasounds and CEUS. High-resolution plaque MRI and&#xD;
      DCE-MRI will be performed in the same patients and will be analyzed by two separate operators&#xD;
      blinded to the results of the CEUS in order to detect the efficacy of CEUS when compared with&#xD;
      in vivo DCE-MRI, as the standard of reference.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plaque neovascularization grading and quantification (assessment by DCE-MRI)</measure>
    <time_frame>Baseline</time_frame>
    <description>Contrast enhanced ultrasound plaque neovascularization grading , correlated to plaque neovascularization quantitative assessment by DCE-MRI.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Carotid Artery Disease</condition>
  <condition>Plaque Neovascularization</condition>
  <arm_group>
    <arm_group_label>Imaging of carotid plaque</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient undergo contrast enhanced ultrasound of the carotid plaque and dynamic contrast-enhanced carotid plaque MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Contrast enhanced ultrasound of the carotid plaque</intervention_name>
    <description>visual grading of neovessel</description>
    <arm_group_label>Imaging of carotid plaque</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dynamic contrast-enhanced carotid plaque MRI</intervention_name>
    <description>quantitative analysis of gadolinium enchantment in a region of interest</description>
    <arm_group_label>Imaging of carotid plaque</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Asymptomatic 50-70% carotid artery stenosis on Doppler ultrasound&#xD;
&#xD;
          -  Asymptomatic &gt;70% carotid artery stenosis on Doppler ultrasound (no surgical&#xD;
             indication)&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non atherosclerotic occlusive disease&#xD;
&#xD;
          -  Prior carotid endarterectomy on the site of the index carotid artery&#xD;
&#xD;
          -  Contraindications for MRI and CE MRI (history of hypersensitivity to gadolinium salt,&#xD;
             pacemaker or vascular clip implantation, implantation of any metallic device, severe&#xD;
             claustrophobic reactions)&#xD;
&#xD;
          -  Contraindications to CEUS (hypersensitivity to Sonovue compounds, acute coronary&#xD;
             syndromes, acute heart failure, heart failure in NYHA class III or IV, severe&#xD;
             arrhythmias, known right-to-left cardiac shunt, severe pulmonary hypertension,&#xD;
             uncontrolled arterial hypertension, acute distress respiratory syndrome)&#xD;
&#xD;
          -  Short-term life-threatening pathology (life expectancy &lt; 6 months)&#xD;
&#xD;
          -  Physically unable to participate in the study&#xD;
&#xD;
          -  Compliance not guaranteed&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augusto Gallino, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mattia Cattaneo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Regionale di Bellinzona e Valli - Ospedale San Giovanni Bellinzona</name>
      <address>
        <city>Bellinzona</city>
        <state>Canton Ticino</state>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Cattaneo M, Staub D, Porretta AP, Gallino JM, Santini P, Limoni C, Wyttenbach R, Gallino A. Data on consistency among different methods to assess atherosclerotic plaque echogenicity on standard ultrasound and intraplaque neovascularization on contrast-enhanced ultrasound imaging in human carotid artery. Data Brief. 2016 Oct 3;9:563-567. eCollection 2016 Dec.</citation>
    <PMID>27752526</PMID>
  </results_reference>
  <results_reference>
    <citation>Cattaneo M, Staub D, Porretta AP, Gallino JM, Santini P, Limoni C, Wyttenbach R, Gallino A. Contrast-enhanced ultrasound imaging of intraplaque neovascularization and its correlation to plaque echogenicity in human carotid arteries atherosclerosis. Int J Cardiol. 2016 Nov 15;223:917-922. doi: 10.1016/j.ijcard.2016.08.261. Epub 2016 Aug 16.</citation>
    <PMID>27597156</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <study_first_submitted>November 26, 2014</study_first_submitted>
  <study_first_submitted_qc>December 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2014</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale San Giovanni Bellinzona</investigator_affiliation>
    <investigator_full_name>Professor Augusto Gallino</investigator_full_name>
    <investigator_title>Professor MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

